Newsletter

South Korea: Upcoming Amendments to the Medical Device Act and Revisions to the Regulation on the Permission, Notification, Review, Etc. of Medical Devices – May/June 2026

South Korea: Upcoming Amendments to the Medical Device Act and Revisions to the Regulation on the Permission, Notification, Review, Etc. of Medical Devices – May/June 2026

  • 2026-06-26 05:40:00

South Korea has introduced amendments to both the Medical Device Act and the Regulation on Medical Device Approval, Notification, and Review, bringing important updates for manufacturers and importers. Key changes include expanded use of real-world evidence (RWE), simplified documentation requirements, a broader transition period for approved changes, and the establishment of a formal quality management system (QMS) conformity recognition framework. The amendments reflect South Korea's ongoing efforts to enhance regulatory efficiency, strengthen oversight, and support innovation in the medical device sector.

More
South Korea: Medical Device Regulatory Update - MFDS Amends Approval, Notification, and Review Rules – January/February 2026

South Korea: Medical Device Regulatory Update - MFDS Amends Approval, Notification, and Review Rules – January/February 2026

  • 2026-02-25 04:14:57

The Ministry of Food and Drug Safety (MFDS) has amended the Regulation on Permission, Notification, Review, Etc. of Medical Devices, effective 26 January 2026. The revision expands acceptable clinical documentation, integrates Class II certification responsibilities, refines the regulatory framework for innovative medical devices, clarifies technical documentation requirements, and strengthens cybersecurity submission obligations for connected devices. These updates aim to enhance regulatory clarity, align with international standards, and improve the efficiency of approval and certification procedures in South Korea.

More